Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.110
-0.130 (-4.01%)
At close: Mar 13, 2026, 4:00 PM EDT
3.000
-0.110 (-3.54%)
After-hours: Mar 13, 2026, 6:14 PM EDT
LIXT Market Cap
LIXT has a market cap or net worth of $17.74 million as of March 13, 2026. Its market cap has increased by 472.26% in one year.
Market Cap
17.74M
Enterprise Value
14.85M
1-Year Change
472.26%
Ranking
Category
Stock Price
$3.11
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $17.74M, a decrease of -62.57%. That is a compound annual growth rate of -16.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 17.70M | -20.98% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 29.65M |
| RenovoRx | 29.61M |
| AEON Biopharma | 29.60M |
| Hyperion DeFi | 28.55M |
| CEL-SCI | 28.49M |
| Kyntra Bio | 28.40M |
| NeuroSense Therapeutics | 28.39M |
| Lantern Pharma | 28.30M |